Risk Mitigation

ASCEND

Eliminate unnecessary trial and error with an AI-augmented experiment path.

ASCEND helps you understand:

What biomarkers can help you validate your hypothesis?

Are there known risks to how effective your approach could be?

Is there evidence of toxic or harmful effects?

How can you reduce unnecessary trial and error?

Improve Visibility and Due Diligence

Review inventory, past purchases, and lab results to optimize resources, spending, and information sharing while reducing project redundancy.

Identify Critical Biomarkers

Discover pertinent biomarkers for prediction, prognosis, safety, and surrogate endpoints. Speed up assessment of biomarker feasibility by uncovering their underlying biological mechanisms and related methodologies.

Flag Obstacles Earlier

Assess risks to experiment strategy and research programs. Identify potential roadblocks towards clinical translation or support the need for alternative avenues.

How Ascend helps with hypothesis generation

The quality of the data is the number one value-add. I can narrow the field down to 2 or 3 candidates, compared to 10 or 20.

— Industry scientist at top 20 pharma, Researcher

60%

success rate

10x

ROI

Learn more!!!

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec lobortis fringilla molestie. Vivamus lobortis mattis arcu, vitae sollicitudin nulla tincidunt et. Pellentesque aliquet facilisis urna in vehicula. Pellentesque rutrum libero non mollis hendrerit. Sed dapibus vestibulum lacus, eu dapibus lacus scelerisque imperdiet.

John Doe, Researcher

24%

Lorem Ipsum

300

Lorem Ipsum

8.5

Lorem Ipsum

John Doe, Researcher

24%

Lorem Ipsum

300

Lorem Ipsum

8.5

Lorem Ipsum

John Doe, Researcher

24%

Lorem Ipsum

300

Lorem Ipsum

8.5

Lorem Ipsum

See how ASCEND Delivers the World’s Biomedical data to your Fingertips.

Learn more

See how we make this work for you

How we work for you